Anemia prevalence in patients with CD4 count of 200–499 cells/μl was 45.1% (32.2% in MHC and 12.9% in OH) and it varies significantly in CD4 count between 200–499 in MHC and OH (P≤0.01, 99% CI). This evidence concerns the gene CD4 and anemia.